Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma
Cancer science, 2021-01, Vol.112 (1), p.305-313 [Peer Reviewed Journal]2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14681 ;PMID: 33047430
Full text available